# ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery

> **NCT01046942** · PHASE3 · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 250 (estimated)

## Conditions studied

- Graft Patency
- Coronary Artery Bypass Grafting Surgery
- Hypercoagulability
- Thrombosis

## Interventions

- **DRUG:** Clopidogrel+acetylsalicylic acid
- **DRUG:** acetylsalicylic acid

## Key facts

- **NCT ID:** NCT01046942
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-09
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2013-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046942, "ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01046942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*